-
Security Type
-
SAFE
-
Min Investment
-
$100
-
Offering Date
-
July 23, 2021
-
Expected Close Date
-
April 30, 2022
-
Target Raise
-
$50.00K-$1.07M
Company Description
We aim to ensure access to quality healthcare for all. We use technology to bridge the gap between telemedicine and in-person exams in a way that is novel, affordable and most of all, patient-oriented. We deliver effective, accessible primary care and socially responsive health services to chronically ill, vulnerable underserved patients while lowering payor costs and improving outcomes through value-based care.
Key Deal Facts
Dramatically improves healthcare access for underserved communities, the elderly, disabled & poor
Treated hundreds of New Yorkers and saved dozens of lives across the Covid pandemic
1000 appointments in NYC. Signed contracts for another 5,500 NY/NJ patients, expanding into Florida
FDA clearance and 7 patents. Approved Medicare vendor (no additional cost to patients)
Total addressable market of $1.2T, ripe for disruption
Founders are health tech experts with 3 successful exits (to IBM, HealthGrades) behind them
Seed is led by the Founder of Eos Health (now Livongo) and founding developer of WhatsApp
Management Team / Advisory Board Bios
Rada Sumareva, CEO
Dr. Rada Sumareva is an advocate for at-risk populations and serves as a Board member of local, national and international non-profits with a focus on inclusion, equality, diversity & access to care.
Dan Kogan, CTO
Dan is a seasoned entrepreneur, software engineer, and application architect. He has brought multiple new digital health products to market with successful acquisitions by IBM and Health Grades.
Gennady Ukrainsky, Chief
R&DGene Ukrainsky, MD, DDS received his MD from Stony Brook Medical Center and completed his residency in Otolaryngoly/Head and Neck Surgery at New York Eye and Ear Infirmary. He is a member of the AOA and OKU (honorary medical and dental societies).